Oxidized-ldl deteriorated the renal residual function and parenchyma in ckd rat through upregulating epithelial mesenchymal transition and extracellular matrix-mediated tubulointerstitial fibrosis—pharmacomodulation of rosuvastatin

HIGHLIGHTS

• who: Pei-Hsun Sung and colleagues from the Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung, Taiwan have published the research: Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosisu2014Pharmacomodulation of Rosuvastatin, in the Journal: (JOURNAL)
• what: The authors intended to delineate the impact of rosuvastatin therapy on alleviating 3.10. The results of Western blot analysis demonstrated that the Dayapoptosis 42 after CKD Induction protein expressions of mitochondrial Bax . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.